As if you needed more issues to consider when picking a birth-control method. Several recent studies have found that some birth-control pills, most notably newer brands such as Yaz and Yasmin, may put women at greater risk for blood clots. According to researchers, pills that contain the synthetic hormone drospirenone, rather than levonorgestrel, put users at twice the risk of developing blood clots. Another study put the risk at 2.7 times greater.
While the overall risk is pretty low, it's still an interesting finding, especially when you consider that Yaz has been the best-selling birth-control pill since its introduction in 2006. (Looks like those cheesy commercials worked.) Bayer, the maker of Yaz and Yasmin has released the following statement, parlaying their skepticism:
Given the already large and robust scientific body of evidence, in Bayer's opinion, these studies do not change the overall assessment about the safety of Bayer's oral contraceptives.
However, this isn't the first time Yaz has come under fire either. The FDA forced them to revise commercials a couple years ago after ads overstated the benefits of the pill, with claims of curing acne and lessening PMS. Oops, I guess when it come to contraceptives, there really is no magic pill.